Publications by authors named "Bayard Powell"

Claim this Profile
M
Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology).
Monica Cusan, Karilyn Larkin, Deedra Nicolet, Vindi Jurinovic, Krzysztof Mrózek, Bayard L Powell

Leukemia· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot study of an inpatient physical activity intervention for older adults treated intensively for acute myeloid leukemia.
Heidi D Klepin, Janet A Tooze, Walter J Rejeski, Shannon Mihalko, Timothy S Pardee, Bayard L Powell

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and Therapeutic Implications of Mutations in Acute Myeloid Leukemia.
Darren Lee, Yazan Abu-Shihab, Kate Plas, Deedra Nicolet, Krzysztof Mrozek, Bayard L Powell

bioRxiv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytarabine Pharmacogenomics and Outcomes Among Children and Young Adults With Acute Myeloid Leukemia.
Richard J Marrero, Vivek M Shastri, Deedra Nicolet, Krzysztof Mrózek, Christopher J Walker, Bayard L Powell

JAMA Netw Open· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic, biological, and structural implications of FLT3-JMD point mutations in acute myeloid leukemia: an analysis of Alliance studies.
Nadeen Anabtawi, Deedra Nicolet, Najla Alotaibi, Daelynn R Buelow, Shelley Orwick, Bayard L Powell

Leukemia· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia.
John M Pagel, Megan Othus, Guillermo Garcia-Manero, Min Fang, Jerald P Radich, Bayard L Powell

JCO Oncol Pract· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of Cancer and Leukemia Group B 10102 (Alliance), a Phase 1/2 Study.
Marlise R Luskin, Jun Yin, Gerard Lozanski, Emily Curran, Gregory Malnassy, Bayard L Powell

Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
White blood cell count levels are associated with inflammatory response and constitute independent outcome predictors in adult patients with acute myeloid leukemia aged <60 years.
Michael Ozga, Deedra Nicolet, Krzysztof Mrózek, Christopher J Walker, James S Blachly, Bayard L Powell

Am J Hematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiomic profiling identifies predictors of survival in African American patients with acute myeloid leukemia.
Andrew Stiff, Maarten Fornerod, Bailee N Kain, Deedra Nicolet, Benjamin J Kelly, Bayard L Powell

Nat Genet· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Mutation Clonal Hierarchy in Acute Myeloid Leukemia.
Sydney Fobare, Chia Sharpe, Kate Quinn, Kinsey Bryant, Linde A Miles, Bayard L Powell

bioRxiv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial.
Marina Y Konopleva, Monique Dail, Naval G Daver, Jacqueline S Garcia, Brian A Jonas, Bayard L Powell

Clin Lymphoma Myeloma Leuk· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Devimistat plus chemotherapy vs chemotherapy alone for older relapsed or refractory patients with AML: results of the ARMADA trial.
Timothy S Pardee, Bayard L Powell, Richard A Larson, Joseph Maly, Michael Keng

Blood Neoplasia· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 Trial.
Scott R Solomon, Bayard L Powell, Jamie Koprivnikar, Catherine Lai, Heather Male

Cancers (Basel)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML.
Guillermo Garcia-Manero, Nikolai A Podoltsev, Megan Othus, John M Pagel, Jerald P Radich, Bayard L Powell

Leukemia· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG).
Michael Ozga, Deedra Nicolet, Krzysztof Mrózek, Ayse S Yilmaz, Jessica Kohlschmidt, Bayard L Powell

Leukemia· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R.
Rahul Lakhotia, Kieron Dunleavy, Jeremy S Abramson, Brian K Link, Bayard L Powell

Blood Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of social deprivation with survival in younger adult patients with AML: an Alliance study.
Melanie Rebechi, Jessica Kohlschmidt, Krzysztof Mrózek, Deedra Nicolet, Alice S Mims, Bayard L Powell

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study.
Bhavana Bhatnagar, Jessica Kohlschmidt, Shelley J Orwick, Daelynn R Buelow, Sydney Fobare, Bayard L Powell

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study.
Krzysztof Mrózek, Jessica Kohlschmidt, James S Blachly, Deedra Nicolet, Andrew J Carroll, Bayard L Powell

Leukemia· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of adult patients with acute lymphoblastic leukemia treated with a modified CALGB 10102 regimen.
Daniel R Reed, Margaux Wooster, Scott Isom, Leslie R Ellis, Dianna S Howard, Bayard L Powell

Ann Hematol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial.
Naval G Daver, Monique Dail, Jacqueline S Garcia, Brian A Jonas, Karen W L Yee, Bayard L Powell

Blood· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML.
Karilyn T Larkin, Deedra Nicolet, Benjamin J Kelly, Krzysztof Mrózek, Stephanie LaHaye, Bayard L Powell

Blood Adv· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of additional cytogenetic abnormalities on survival in arsenic trioxide-treated acute promyelocytic leukemia.
Zachary D Epstein-Peterson, Andriy Derkach, Susan Geyer, Krzysztof Mrózek, Jessica Kohlschmidt, Bayard L Powell

Blood Adv· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tailoring a physical activity intervention to older adults receiving intensive chemotherapy for acute myeloid leukemia (AML): One size does not fit all.
Heidi D Klepin, Janet A Tooze, Jack Rejeski, Shannon Mihalko, Timothy S Pardee, Bayard L Powell

J Geriatr Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia.
Rebecca Anderson, Lance D Miller, Scott Isom, Jeff W Chou, Kristin M Pladna, Bayard L Powell

Nat Commun· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis